Baxter International (BAX) Equity Average (2009 - 2026)

Baxter International (BAX) has 18 years of Equity Average data on file, last reported at $6.1 billion in Q1 2026.

• Quarterly Equity Average fell 13.73% year-over-year to $6.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.1 billion (down 13.73% YoY) and the FY2025 annual result came in at $6.6 billion, down 15.1% from the prior year.
• Equity Average slipped to $6.1 billion in Q1 2026 per BAX's latest filing, from $6.7 billion in the prior quarter.
• Across five years, Equity Average topped out at $9.1 billion in Q1 2022 and bottomed at $5.7 billion in Q4 2022.
• The 5-year median for Equity Average is $7.2 billion (2022), against an average of $7.3 billion.
• The widest annual swing landed in 2022, when Equity Average tumbled 36.03%; it then surged 44.97% in 2023.
• Tracing BAX's Equity Average over 5 years: stood at $5.7 billion in 2022, then surged by 44.97% to $8.3 billion in 2023, then declined by 10.03% to $7.5 billion in 2024, then decreased by 10.66% to $6.7 billion in 2025, then declined by 9.16% to $6.1 billion in 2026.
• Per Business Quant, the three latest BAX Equity Average figures stand at $6.1 billion (Q1 2026), $6.7 billion (Q4 2025), and $7.3 billion (Q3 2025).

Peer Comparison